DDMAC News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Say so long to DDMAC as FDA's OPDP levels up - Medical Marketing and Media



Say so long to DDMAC as FDA's OPDP levels up 
Medical Marketing and Media
The FDA gave its Office of Medical Policy a long-awaited org chart upgrade, making it a ?super office? and giving the department formerly known as the Division of Drug Marketing, Advertising and Communication, or DDMAC, a new acronym: OPDP. Under the ...

 


DDMAC slaps Premarin patient testimonials, Acuvail journal ad - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC slaps Premarin patient testimonials, Acuvail journal ad 
Medical Marketing and Media
With respect to risk minimization, DDMAC took issue with the ?colorful, audio-visual testimonials? of the five women sharing their positive experiences with Premarin, as compared with Premarin's risk info, which was ?relegated to the bottom portion of ...

and more » 


Intuniv patient kit draws DDMAC untitled letter - Medical Marketing and Media



Medical Marketing and Media
 
Intuniv patient kit draws DDMAC untitled letter 
Medical Marketing and Media
Patient materials for Shire's ADHD drug Intuniv presented unsubstantiated effectiveness and superiority claims and downplayed important risk info, said the FDA's Division of Drug Marketing, Advertising and Communication. In a June 22 untitled letter ...

and more » 


DDMAC pokes Allergan on eye drop direct mail - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC pokes Allergan on eye drop direct mail 
Medical Marketing and Media
Allergan has a superiority complex when it comes to marketing its ophthalmic drops, as evidenced by a second DDMAC Untitled Letter posted online yesterday. This time, a direct mail piece targeting physicians made unsubstantiated superiority claims ...

and more » 


DDMAC cites fishy Cymbalta fibromyalgia ads - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC cites fishy Cymbalta fibromyalgia ads 
Medical Marketing and Media
A consumer print ad for the brand's fibromyalgia indication fails to adequately communicate risks of use, the letter, from the agency's Division of Drug Marketing, Advertising and Communication, said. Risk information was presented on a separate page ...

 


DDMAC slaps J&J journal ad, Pedinol mailer - Medical Marketing and Media



Medical Marketing and Media
 
DDMAC slaps J&J journal ad, Pedinol mailer 
Medical Marketing and Media
The FDA issued an untitled letter to Johnson & Johnson for a journal ad for its athlete's foot treatment Ertaczo Cream, saying the ad omits key risk info, broadens the indication and overhypes efficacy. Among other things, agency reviewers took issue ...

and more » 


DDMAC warns Novartis on educational websites - Medical Marketing and Media



DDMAC warns Novartis on educational websites 
Medical Marketing and Media
FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) took Novartis to school over educational websites the agency said went beyond disease awareness, and into brand promotion, according to a Warning Letter dated April 21. Although ...

and more » 


DDMAC loses a letter but gains a new name and more prominence - Lexology



DDMAC loses a letter but gains a new name and more prominence 
Lexology
It's time to learn a new acronym. The Food and Drug Administration's (FDA's) Division of Drug Marketing, Advertising, and Communications (DDMAC) is now the newly-named Office of Prescription Drug Promotion, or OPDP. Elevation to an ?Office? status ...

 


DDMAC demands corrective messaging from three companies - Medical Marketing and Media



DDMAC demands corrective messaging from three companies 
Medical Marketing and Media
The FDA hit three companies with warning letters for promotional materials on three drugs and requested corrective communications for all three. The move suggests that requests for corrective communications -- which could range from "Dear Doctor ...

 


GSK awareness ad for Arzerra a stealth product promotion, says FDA - Medical Marketing and Media



Medical Marketing and Media
 
GSK awareness ad for Arzerra a stealth product promotion, says FDA 
Medical Marketing and Media
As to why the ad was considered promotional, the FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) stated in the letter, ?The characteristics of the product promoted in the ad can only describe Arzerra. Not only is Arzerra the ...

and more »